GlassScriptPhysician profile
Charles R Prince
NPI 1861429615
$1,430.57
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $75.27 · 2021: $178 · 2022: $297 · 2023: $246 · 2024: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $266.43 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $165.76 | 2019-2022 | |
| Pfizer INC. | $138.79 | 2019-2024 | |
| Abbott Laboratories | $121.33 | 2019-2023 | Mini Trek |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.33 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $68.91 | 2019-2024 | Farxiga |
| Boston Scientific Corporation | $64.39 | 2019-2023 | Bodyguardian |
| Cardiovascular Systems INC. | $58.79 | 2019-2021 | |
| Esperion Therapeutics, INC. | $48.21 | 2022-2023 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $41.31 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $39.34 | 2024 | Assure Wcd |
| Terumo Medical Corporation | $36.31 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $33.63 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $33.45 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $33.21 | 2019-2023 | Evkeeza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $32.88 | 2022 | |
| Merck Sharp & Dohme LLC | $32.38 | 2023-2024 | Verquvo |
| Novo Nordisk INC | $26.53 | 2019-2020 | |
| Chiesi USA, INC. | $22.85 | 2022 | |
| Philips North America LLC | $18.82 | 2023 | |
| Ge Healthcare | $18.40 | 2022 | |
| Amgen INC. | $18.39 | 2021 | |
| Medtronic USA, INC. | $15.27 | 2019 | |
| Medtronic Vascular, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.